Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Outcomes of Laparoscopy-Assisted Surgery in Elderly Patients with Colorectal Carcinoma]Yoshiko Fujikawa, Seiji Hasegawa, Yuuki Doi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Stage IV Gastric Cancer Successfully Treated Using Salvage Surgery after S-1/CDDP Therapy]Yuko Shimada, Tsutomu Hayashi, Keisuke Minamizawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 17, 2009
[Long survival of a case of unresected duodenal cancer treated by S-1 before and after duodenojejunostomy]Kenichi Matsuzu, Hideyuki Ike, Haruhiko Cho, et al.Oncology Reports|January 5, 2006
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cellsYasushi Ichikawa, Takashi Ishikawa, Nobuyoshi Momiyama, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[Gallbladder Malignant Lymphoma Diagnosed after Surgery for Acute Cholecystitis - A Case Report]Yuna Sudo, Ryo Takagawa, Kaori Kohagura, et al.BJS Open|March 8, 2022
Optimizing nodal and staging classification in low rectal cancers with lateral node metastasis: multicentre retrospective cohort studyEiji Shinto, Hideyuki Ike, Masaaki Ito, et al.International Journal of Clinical Oncology|October 14, 2024
Lateral node metastasis in low rectal cancer as a hallmark to predict recurrence patternsEiji Shinto, Hideyuki Ike, Masaaki Ito, et al.Journal of Gastroenterology|April 15, 2005
Primary malignant peripheral nerve-sheath tumor of the common bile ductKen-ichi Matsuo, Yasuhiko Nagano, Kazuya Sugimori, et al.Annals of Surgery|February 7, 2022
The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III TrialYasumasa Takii, Junki Mizusawa, Yukihide Kanemitsu, et al.International Journal of Clinical Oncology|January 13, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.Pageof 6